A 56-year-old male with worsening renal function and stage 3 chronic kidney disease presents with proteinuria and elevated blood pressure. Which nursing intervention is most appropriate to help manage his condition?

B) Teach the patient to monitor blood pressure at home and report readings over 140/90 mmHg

A) Encourage a high-protein diet to support tissue repair

B) Teach the patient to monitor blood pressure at home and report readings over 140/90 mmHg

C) Advise the patient to increase fluid intake to promote renal clearance

D) Recommend daily weight monitoring to assess for fluid retention

A 56-year-old male patient with stage 3 chronic kidney disease presents with elevated blood pressure of 160/95 mmHg, proteinuria, and decreased eGFR. His medical history includes uncontrolled hypertension and diabetes. Which intervention should the nurse prioritize to help slow the progression of renal disease?

C) Educate the patient on adhering to prescribed antihypertensive medications and maintaining blood pressure control.

A) Increase dietary protein intake to support kidney function.

B) Encourage the patient to increase fluid intake to flush the kidneys.

C) Educate the patient on adhering to prescribed antihypertensive medications and maintaining blood pressure control.

D) Advise the patient to take over-the-counter NSAIDs for pain management.

A patient with hypertension and diabetes has been started on an ACE inhibitor and presents with serum potassium level of 5.6 mEq/L and reports of dizziness upon standing. What is the most appropriate nursing intervention to address the patient's condition?

B) Instruct the patient to rise slowly from a sitting or lying position to prevent dizziness.

A) Encourage the patient to increase dietary potassium intake to counteract the dizziness.

B) Instruct the patient to rise slowly from a sitting or lying position to prevent dizziness.

C) Advise the patient to double the dose of insulin to manage suboptimal glycemic control.

D) Recommend the patient reduce fluid intake to manage potential fluid overload.

A patient with hypertension and diabetes mellitus is experiencing persistent fatigue, dizziness upon standing, and hyperkalemia after starting an ACE inhibitor. What is the most appropriate nursing action to address these concerns?

B) Educate the patient on low-potassium dietary choices to help manage hyperkalemia.

A) Encourage the patient to increase daily fluid intake to manage dizziness and fluid retention.

B) Educate the patient on low-potassium dietary choices to help manage hyperkalemia.

C) Instruct the patient to increase salt intake to counteract the effects of the ACE inhibitor.

D) Recommend the patient stop taking insulin temporarily until glycemic control is improved.

A patient with a history of hypertension, renal impairment, and recent transition from an ACE inhibitor to a calcium channel blocker presents with peripheral edema and shortness of breath. Which nursing intervention is most appropriate to address the patient's current symptoms and support interdisciplinary care?

C) Monitor daily weights and assess for signs of worsening edema.

A) Administer supplemental oxygen to alleviate shortness of breath.

B) Encourage increased fluid intake to promote renal perfusion.

C) Monitor daily weights and assess for signs of worsening edema.

D) Increase the dosage of the calcium channel blocker for better blood pressure control.

A patient with complex renal and metabolic conditions is switched from an ACE inhibitor to a calcium channel blocker, subsequently developing peripheral edema and shortness of breath. Which nursing intervention is most appropriate to address these symptoms while considering the patient's current treatment plan?

D) Monitor daily weights and report significant changes to the healthcare provider.

A) Increase the dosage of furosemide to promote diuresis.

B) Educate the patient on reducing fluid intake to 1.5 liters per day.

C) Reintroduce the ACE inhibitor to improve diuresis and reduce edema.

D) Monitor daily weights and report significant changes to the healthcare provider.

A patient with heart failure with reduced ejection fraction (HFrEF) and recent initiation of low-dose furosemide therapy presents with a decreased serum sodium level of 133 mEq/L. Which intervention should the nurse prioritize to address the potential hyponatremia while considering the patient's overall condition?

B) Implement a fluid restriction to prevent further dilutional hyponatremia.

A) Increase the dose of furosemide to enhance diuresis and reduce fluid retention.

B) Implement a fluid restriction to prevent further dilutional hyponatremia.

C) Administer hypertonic saline to rapidly correct the hyponatremia.

D) Encourage the patient to increase dietary sodium intake to correct the imbalance.

A patient with heart failure with reduced ejection fraction (HFrEF) and recent initiation of low-dose furosemide therapy shows a decrease in serum sodium to 133 mEq/L and a mildly reduced ejection fraction of 45%. Which nursing intervention is most appropriate to address the patient's current clinical status?

B) Monitor the patient's blood pressure and heart rate before initiating a beta-blocker.

A) Encourage the patient to increase fluid intake to address hyponatremia.

B) Monitor the patient's blood pressure and heart rate before initiating a beta-blocker.

C) Restrict the patient's potassium intake to prevent hyperkalemia.

D) Discontinue furosemide therapy to prevent further decrease in sodium levels.

A patient with a recent medication adjustment presents with oliguria, worsening peripheral edema, and a drop in serum sodium levels. The healthcare team suspects worsening heart failure with renal involvement. What is the priority nursing intervention to address the patient's condition?

C) Monitor vital signs and urine output closely while adjusting medication as prescribed.

A) Increase the dosage of diuretics to manage fluid overload.

B) Administer a fluid bolus to improve renal perfusion.

C) Monitor vital signs and urine output closely while adjusting medication as prescribed.

D) Encourage the patient to increase oral fluid intake to correct hyponatremia.

A patient with a history of heart failure is experiencing persistent fatigue, decreased urine output, and worsening peripheral edema despite diuretic therapy. Laboratory tests show hyponatremia, elevated serum creatinine, and metabolic acidosis. Which of the following interventions is most appropriate to prioritize in managing this patient's condition?

C) Initiate inotropic support to improve cardiac output.

A) Increase the dose of diuretics to enhance fluid removal.

B) Administer hypertonic saline to correct hyponatremia rapidly.

C) Initiate inotropic support to improve cardiac output.

D) Restrict sodium and fluid intake to manage fluid overload.

renal - Nursing Case Study

Pathophysiology

• Primary mechanism: Glomerular filtration impairment - Damage to the glomeruli, often due to conditions like diabetes or hypertension, reduces the kidney's ability to filter waste and excess fluid from the blood, leading to toxin accumulation and fluid overload.

• Secondary mechanism: Tubular dysfunction - Injury or disease affecting the renal tubules, such as acute tubular necrosis, disrupts reabsorption and secretion processes, leading to imbalances in electrolytes and fluids, and further exacerbating renal impairment.

• Key complication: Progression to chronic kidney disease - Persistent impairment in filtration and tubular function can lead to irreversible kidney damage, decreasing renal function progressively and potentially culminating in end-stage renal disease requiring dialysis or transplantation.

Patient Profile

Demographics:

56-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes

• Current medications: Lisinopril, Metformin, Insulin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Fatigue and swelling in legs

• Key symptoms: Decreased urine output, shortness of breath, nausea

• Vital signs: Blood pressure 160/95 mmHg, heart rate 98 bpm, respiratory rate 22 breaths per minute, temperature 98.7°F, oxygen saturation 93% on room air

Section 1

As the healthcare team continues to monitor the 56-year-old male patient, new diagnostic results reveal significant concerns. Laboratory tests indicate elevated blood urea nitrogen (BUN) at 45 mg/dL and creatinine at 3.2 mg/dL, both suggesting worsening renal function. Additionally, the patient's estimated glomerular filtration rate (eGFR) has decreased to 30 mL/min/1.73 m², indicating stage 3 chronic kidney disease. Urinalysis reveals proteinuria, with a protein excretion rate of 1.5 g/day, and microscopic hematuria. These findings suggest further damage to the glomerular filtration barrier, likely exacerbated by uncontrolled hypertension and diabetes.

In light of these results, it becomes evident that the patient's renal impairment is progressing, necessitating a reevaluation of his current management plan. The healthcare team must consider adjusting the patient's antihypertensive therapy, as his blood pressure remains elevated at 160/95 mmHg. It is crucial to achieve better blood pressure control to minimize additional damage to the renal vasculature. Glycemic control should also be addressed, as persistent hyperglycemia can worsen nephropathy. The potential addition of diuretics may be considered to manage fluid overload and reduce peripheral edema.

The identification of these new complications prompts the need for a multidisciplinary approach, involving nephrologists, dietitians, and diabetes educators. Patient education will focus on lifestyle modifications, dietary restrictions, and adherence to medication regimens to slow the progression of renal disease. As the patient's journey unfolds, the healthcare team must remain vigilant in monitoring for further complications, such as electrolyte imbalances or cardiovascular issues, and be prepared to adjust the treatment plan accordingly to optimize patient outcomes.

Section 2

Change in Patient Status:

Following the implementation of adjusted treatment strategies, the patient's clinical status presents mixed outcomes. On assessment, there is a modest improvement in blood pressure, now reading 150/90 mmHg, following the initiation of an angiotensin-converting enzyme (ACE) inhibitor to better manage hypertension and provide renal protection. However, despite these changes, the patient reports persistent fatigue and episodes of dizziness, particularly upon standing, indicating potential orthostatic hypotension, a side effect of the new medication regimen.

Moreover, recent laboratory tests reveal a concerning development: serum potassium levels have risen to 5.6 mEq/L, suggesting hyperkalemia, likely as a result of the ACE inhibitor therapy. This electrolyte imbalance necessitates a careful review of the patient's medication and dietary intake, considering the risk of cardiac complications. The healthcare team decides to temporarily halt the ACE inhibitor and consult with a nephrologist to evaluate alternative antihypertensive options that can mitigate hyperkalemia and better support renal function.

Simultaneously, the patient's glycemic control remains suboptimal, with a recent HbA1c level of 8.2%, underscoring the need for intensified efforts in diabetes management. The diabetes educator collaborates with the patient to reinforce education on carbohydrate counting and insulin administration, while also considering adjustments to the insulin regimen to achieve tighter glycemic control. As the healthcare team navigates these challenges, they remain vigilant for signs of fluid overload, as the patient's weight has increased by 2 kg over the past week, hinting at potential fluid retention. This prompts discussions about initiating low-dose diuretic therapy while monitoring renal response, ensuring a balanced approach to managing the patient's complex and evolving condition.

Section 3

As the healthcare team continues to manage the patient's complex renal and metabolic conditions, a new complication arises. The nephrologist recommends a switch to a calcium channel blocker to manage the patient's hypertension while minimizing the risk of hyperkalemia. However, within days of this adjustment, the patient presents with new symptoms of peripheral edema and shortness of breath, particularly noticeable during physical activity. These symptoms suggest a possible exacerbation of fluid overload, potentially related to the recent increase in weight and the cessation of the ACE inhibitor, which had provided some degree of diuresis.

On further examination, the patient's vital signs show a blood pressure of 160/95 mmHg, a heart rate of 98 beats per minute, and respiratory rate of 22 breaths per minute with mild accessory muscle use. Auscultation reveals faint bilateral crackles at the lung bases, indicating fluid accumulation. Laboratory tests confirm a continued rise in serum creatinine to 2.1 mg/dL from a previous 1.8 mg/dL, suggesting worsening renal function. The serum potassium level has stabilized at 5.0 mEq/L following dietary adjustments, but the concern shifts to managing the patient's fluid status and potential heart failure exacerbation.

In response, the healthcare team initiates low-dose furosemide therapy to address the fluid overload while closely monitoring renal function and electrolyte balance. The patient is advised to maintain a low-sodium diet to support fluid management. The situation necessitates careful collaboration between the nephrology and cardiology teams to optimize both renal and cardiovascular function. The patient is scheduled for follow-up assessments to monitor the effectiveness of the interventions and to adjust the treatment plan as needed, highlighting the importance of continuous evaluation and interdisciplinary communication in managing such multifaceted health issues.

Section 4

As the healthcare team continues to monitor the patient's progress following the initiation of low-dose furosemide therapy, new diagnostic results shed light on the evolving clinical picture. Repeat laboratory tests reveal a slight decrease in serum creatinine to 2.0 mg/dL, suggesting a mild improvement in renal function. However, the patient's serum sodium level has decreased to 133 mEq/L, raising concerns about potential hyponatremia. Although the patient's serum potassium remains stable at 4.8 mEq/L, there is a noted decrease in serum bicarbonate to 20 mEq/L, indicating a possible metabolic acidosis that may complicate the patient's overall clinical status.

The healthcare team performs an echocardiogram to evaluate the patient's cardiac function in light of the persistent shortness of breath and peripheral edema. The results reveal a mildly reduced ejection fraction of 45%, consistent with heart failure with reduced ejection fraction (HFrEF). This finding necessitates a reevaluation of the patient's medication regimen to optimize heart failure management while continuing to support renal function. Given the patient's complex presentation, the cardiology team considers the cautious introduction of a beta-blocker to improve heart function, with the understanding that close monitoring for any adverse effects on renal function is essential.

In response to these developments, the healthcare team emphasizes the importance of a multidisciplinary approach, involving nephrology, cardiology, and nutrition services to ensure comprehensive care. The patient is counseled on the need for adherence to the low-sodium diet and is educated on recognizing signs of worsening heart failure or renal impairment. Follow-up appointments are scheduled to reassess the patient's condition and adjust the treatment plan as necessary. This ongoing evaluation highlights the dynamic nature of managing complex interrelated conditions, where clinical reasoning plays a critical role in navigating potential complications and optimizing patient outcomes.

Section 5

A few days following the adjustment in the patient's medication regimen, the healthcare team notes a change in the patient's status. The patient reports persistent fatigue and a decrease in urine output, now producing only 400 mL over the past 24 hours, which is concerning for oliguria. In addition, the patient's blood pressure has dropped to 100/60 mmHg, and there is a noted increase in heart rate to 110 beats per minute. Physical examination reveals worsening peripheral edema and mild jugular venous distention, suggesting fluid overload despite the diuretic therapy.

Repeat laboratory tests show a further drop in serum sodium to 130 mEq/L, exacerbating the hyponatremia. The serum creatinine level has increased slightly to 2.5 mg/dL, indicating a decline in renal function. Additionally, the serum bicarbonate level remains low at 18 mEq/L, confirming the presence of metabolic acidosis. These findings suggest that the patient may be experiencing worsening heart failure, compounded by the challenge of balancing renal perfusion and fluid management.

In light of these developments, the healthcare team revisits the patient's treatment plan. The nephrology team recommends cautious diuretic adjustment to address fluid overload while minimizing further renal insult. Meanwhile, the cardiology team evaluates the potential need for inotropic support to enhance cardiac output without compromising renal function. The patient's fluid and electrolyte status is closely monitored, and the importance of adherence to dietary and medication instructions is reinforced. This situation underscores the need for vigilant clinical reasoning and dynamic adjustment of the care plan to navigate the complexities of the patient's interrelated conditions.